Photodynamic therapy: a review and its prospective role in the management of oral potentially malignant disorders

被引:33
作者
Saini, R. [1 ,2 ]
Poh, C. F. [1 ,2 ]
机构
[1] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada
[2] Univ British Columbia, Dept Oral Biol & Med Sci, Fac Dent, Vancouver, BC V6T 1Z3, Canada
基金
加拿大健康研究院;
关键词
topical; photodynamic therapy; oral potentially malignant disorders; oral dysplasia; TOPICAL 5-AMINOLEVULINIC ACID; INDUCED PROTOPORPHYRIN IX; SQUAMOUS-CELL CARCINOMA; LIGHT-EMITTING DIODE; IN-VIVO; VERRUCOUS HYPERPLASIA; PREMALIGNANT LESIONS; FOLLOW-UP; ENDOGENOUS PROTOPORPHYRIN; PHOTORADIATION THERAPY;
D O I
10.1111/odi.12003
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
With the unreliability of epithelial dysplasia as a predictor to determine the risk of future malignant development, subjectivity associated in evaluating dysplasia by pathologists and paucity of biomarkers that could accurately predict the progression risks in oral potentially malignant disorders (PMDs), eradication of the lesions appears to be the most desirable approach to minimize the risk of invasive cancer formation. Interventions, such as surgery and chemoprevention, have not shown promising long-term results in the treatment of these lesions, and lack of guidelines and general consensus on their management has incited much anxiety and doubts in both patients and community clinicians. Topical photodynamic therapy (PDT) is a minimally invasive and minimally toxic technique that in recent years has shown great promise in the management of PMDs. In this review, we describe the historical developments in the field of PDT, its basic mechanisms, as well as related clinical studies, and its challenges in the management of oral PMDs. Based on its high efficacy and low side effects, its high patient acceptance/compliance, the simplicity of the procedure and its minimal pretreatment preparation, topical PDT is believed to have potential to play an important role in the management of PMDs, especially of the low-grade dysplasia.
引用
收藏
页码:440 / 451
页数:12
相关论文
共 146 条
  • [1] Ackroyd R, 2001, PHOTOCHEM PHOTOBIOL, V74, P656, DOI 10.1562/0031-8655(2001)074<0656:THOPAP>2.0.CO
  • [2] 2
  • [3] AGARWAL ML, 1991, CANCER RES, V51, P5993
  • [4] Regulatory pathways in photodynamic therapy induced apoptosis
    Agostinis, P
    Buytaert, E
    Breyssens, H
    Hendrickx, N
    [J]. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, 2004, 3 (08) : 721 - 729
  • [5] Oncologic photodynamic therapy photosensitizers: A clinical review
    Allison, Ron R.
    Sibata, Claudio H.
    [J]. PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2010, 7 (02) : 61 - 75
  • [6] Intracellular signaling mechanisms in photodynamic therapy
    Almeida, RD
    Manadas, BJ
    Carvalho, AP
    Duarte, CB
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2004, 1704 (02): : 59 - 86
  • [7] In vitro and in vivo comparison of two different light sources for topical photodynamic therapy
    Babilas, P
    Kohl, E
    Maisch, T
    Bäcker, H
    Gross, B
    Branzan, AL
    Bäumler, W
    Landthaler, M
    Karrer, S
    Szeimies, RM
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (04) : 712 - 718
  • [8] Light-Emitting Diodes (LEDs) in Dermatology
    Barolet, Daniel
    [J]. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2008, 27 (04) : 227 - 238
  • [9] Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX
    Barr, H
    Shepherd, NA
    Dix, A
    Roberts, DJH
    Tan, WC
    Krasner, N
    [J]. LANCET, 1996, 348 (9027) : 584 - 585
  • [10] Bodner K, 2003, ANTICANCER RES, V23, P1785